Literature DB >> 32147976

Towards Implementation of the Saint Vincent Declaration: Outcomes of Women with Pregestational Diabetes.

Rakefet Yoeli-Ullman1, Nimrod Dori-Dayan1, Shali Mazaki-Tovi1, Roni Zemet1, Neomi Kedar1, Ohad Cohen2, Tali Cukierman-Yaffe2.   

Abstract

BACKGROUND: Pregestational diabetes mellitus (PGDM) carries a significantly elevated risk of adverse maternal and fetal outcomes. There is evidence that certain interventions reduce the risk for adverse outcomes. Studies have shown that a multi-disciplinary approach improves pregnancy outcomes in women with PGDM.
OBJECTIVES: To determine pregnancy outcomes in women with PGDM using a multi-disciplinary approach.
METHODS: We retrospectively reviewed consecutive women with pregestational type 1 and type 2 diabetes who were monitored at a high-risk pregnancy clinic at the Sheba Medical Center. Clinical data were obtained from the medical records. All data related to maternal glucose control and insulin pump function were prospectively recorded on Medtronic CareLink® pro software (Medtronic MiniMed, Northridge, CA).
RESULTS: This study comprised 121 neonates from 116 pregnancies of 94 women. In 83% of the pregnancies continuous glucose monitoring (CGM) sensors were applied during a part or all of the pregnancy. Pregnancy outcomes among women who were followed by a multi-disciplinary team before and during pregnancy, and during labor and puerperium resulted in better glucose control (hemoglobin A1c 6.4% vs. 7.8%), lower risk for pregnancy induced hypertension/preeclampsia (7.7% vs. 15.6%), lower birth weight (3212 g vs. 3684 g), and lower rate of large size for gestational age and macrosomia (23.1% vs. 54.2% and 3.3% vs. 28.4%, respectively), compared to data from European cohorts.
CONCLUSIONS: The multi-disciplinary approach for treating women with PGDM practiced in the high-risk pregnancy clinic at the Sheba Medical Center resulted in lower rates of macrosomia, LGA, and pregnancy induced hypertension compared to rates reported in the literature.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32147976

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


  2 in total

1.  Global Estimates of Diabetic Retinopathy Prevalence and Progression in Pregnant Women With Preexisting Diabetes: A Systematic Review and Meta-analysis.

Authors:  Felicia Widyaputri; Sophie L Rogers; Rathika Kandasamy; Alexis Shub; Robert C A Symons; Lyndell L Lim
Journal:  JAMA Ophthalmol       Date:  2022-05-01       Impact factor: 8.253

2.  Planned vaginal and planned cesarean delivery outcomes in pregnancies complicated with pregestational type 1 diabetes - A three-year academic tertiary hospital cohort study.

Authors:  Heidi Kruit; Saara Mertsalmi; Leena Rahkonen
Journal:  BMC Pregnancy Childbirth       Date:  2022-03-02       Impact factor: 3.007

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.